Literature DB >> 15456747

MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.

Chun-Ling Jiang1, Seung-Gi Jin, Gerd P Pfeifer.   

Abstract

Methyl-CpG-binding domain proteins 2 and 3 (MBD2 and MBD3) are transcriptional repressors that contain methyl-CpG binding domains and are components of a CpG-methylated DNA binding complex named MeCP1. Methyl-CpG-binding protein 3-like 1 (MBD3L1) is a protein with substantial homology to MBD2 and MBD3, but it lacks the methyl-CpG binding domain. MBD3L1 interacts with MBD2 and MBD3 in vitro and in yeast two-hybrid assays. Gel shift experiments with a CpG-methylated DNA probe indicate that recombinant MBD3L1 can supershift an MBD2-methylated DNA complex. In vivo, MBD3L1 associates with and colocalizes with MBD2 but not with MBD3 and is recruited to 5-methylcytosine-rich pericentromeric heterochromatin in mouse cells. In glutathione S-transferase pull-down assays MBD3L1 is found associated with several known components of the MeCP1.NuRD complex, including HDAC1, HDAC2, MTA2, MBD2, RbAp46, and RbAp48, but MBD3 is not found in the MBD3L1-bound fraction. MBD3L1 enhances transcriptional repression of methylated DNA by MBD2. The data are consistent with a role of MBD3L1 as a methylation-dependent transcriptional repressor that may interchange with MBD3 as an MBD2-interacting component of the NuRD complex. MBD3L1 knockout mice were created and were found to be viable and fertile, indicating that MBD3L1 may not be essential or there is functional redundancy (through MBD3) in this pathway. Overall, this study reveals additional complexities in the mechanisms of transcriptional repression by the MBD family proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15456747     DOI: 10.1074/jbc.M409149200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.

Authors:  Satish Kalari; Gerd P Pfeifer
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

2.  MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.

Authors:  Xavier Le Guezennec; Michiel Vermeulen; Arie B Brinkman; Wieteke A M Hoeijmakers; Adrian Cohen; Edwin Lasonder; Hendrik G Stunnenberg
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

3.  Eyes on DNA methylation: current evidence for DNA methylation in ocular development and disease.

Authors:  Deborah C Otteson
Journal:  J Ocul Biol Dis Infor       Date:  2012-03-29

4.  An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex.

Authors:  Megha A Desai; Heather D Webb; Leander M Sinanan; J Neel Scarsdale; Ninad M Walavalkar; Gordon D Ginder; David C Williams
Journal:  Nucleic Acids Res       Date:  2015-03-09       Impact factor: 16.971

5.  Dissecting the behavior and function of MBD3 in DNA methylation homeostasis by single-molecule spectroscopy and microscopy.

Authors:  Yi Cui; Joseph Irudayaraj
Journal:  Nucleic Acids Res       Date:  2015-03-09       Impact factor: 16.971

6.  Whole DNA methylome profiling in mice exposed to secondhand smoke.

Authors:  Stella Tommasi; Albert Zheng; Jae-In Yoon; Arthur Xuejun Li; Xiwei Wu; Ahmad Besaratinia
Journal:  Epigenetics       Date:  2012-10-10       Impact factor: 4.528

7.  The MIRA method for DNA methylation analysis.

Authors:  Tibor A Rauch; Gerd P Pfeifer
Journal:  Methods Mol Biol       Date:  2009

8.  Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine.

Authors:  Seung-Gi Jin; Swati Kadam; Gerd P Pfeifer
Journal:  Nucleic Acids Res       Date:  2010-04-05       Impact factor: 16.971

9.  In vitro nuclear interactome of the HIV-1 Tat protein.

Authors:  Virginie W Gautier; Lili Gu; Niaobh O'Donoghue; Stephen Pennington; Noreen Sheehy; William W Hall
Journal:  Retrovirology       Date:  2009-05-19       Impact factor: 4.602

10.  Methyl-CpG-binding PCR of bloodspots for confirmation of fragile X syndrome in males.

Authors:  Ching-Cherng Tzeng; Chiou-Ping Liou; Chien-Feng Li; Ming-Chi Lai; Li-Ping Tsai; Wei-Chen Cho; Hui-Ting Chang
Journal:  J Biomed Biotechnol       Date:  2009-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.